14584021

Source:http://linkedlifedata.com/resource/pubmed/id/14584021

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0087111, umls-concept:C0717758
pubmed:issue	4
pubmed:dateCreated	2003-10-29
pubmed:abstractText	Etanercept is a soluble tumour necrosis factor alpha-receptor DMARD for the treatment of rheumatoid arthritis (RA).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/14584021-15230563
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100909747
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein
pubmed:status	MEDLINE
pubmed:issn	1469-493X
pubmed:author	pubmed-author:BlumenauerBB, pubmed-author:BurlsAA, pubmed-author:CoyleDD, pubmed-author:CranneyAA, pubmed-author:HochbergMM, pubmed-author:JudeJJ, pubmed-author:TugwellPP, pubmed-author:WellsGG
pubmed:issnType	Electronic
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	CD004525
pubmed:dateRevised	2009-11-3
pubmed:meshHeading	pubmed-meshheading:14584021-Antirheumatic Agents, pubmed-meshheading:14584021-Arthritis, Rheumatoid, pubmed-meshheading:14584021-Humans, pubmed-meshheading:14584021-Immunoglobulin G, pubmed-meshheading:14584021-Methotrexate, pubmed-meshheading:14584021-Randomized Controlled Trials as Topic, pubmed-meshheading:14584021-Receptors, Tumor Necrosis Factor
pubmed:year	2003
pubmed:articleTitle	Etanercept for the treatment of rheumatoid arthritis.
pubmed:publicationType	Journal Article, Review, Meta-Analysis